These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9532206)

  • 1. Surgical and chemical approaches to regulate hyperinsulinemia after pancreas transplantation in rats.
    Uchiyama K; Nakai I; Mitsuo M; Shimizu Y; Oka T; Takata Y; Kobayashi M
    Transplant Proc; 1998 Mar; 30(2):631-2. PubMed ID: 9532206
    [No Abstract]   [Full Text] [Related]  

  • 2. Elimination of hyperinsulinemia after pancreas transplantation in rats.
    Nakai I; Uchiyama K; Mitsuo M; Mizuta N; Okamoto M; Nakajima H; Yoshimura N; Omori Y; Oka T
    Transplant Proc; 1999 Aug; 31(5):2010-1. PubMed ID: 10455956
    [No Abstract]   [Full Text] [Related]  

  • 3. New directions in treating insulin resistance.
    Reusch JE
    Hosp Pract (1995); 1995 Sep; 30(9):9-10. PubMed ID: 7559840
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of troglitazone on blood insulin levels after pancreas transplantation with systemic venous drainage in rats.
    Uchiyama K; Nakai I; Shimizu Y; Mitsuo M; Yasunami Y; Oka T
    Transplantation; 1997 Nov; 64(10):1476-8. PubMed ID: 9392315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperinsulinaemia in polycystic ovary syndrome?
    van Montfrans JM; van Hooff MH; Hompes PG; Lambalk CB
    Hum Reprod; 1998 Jan; 13(1):5-6. PubMed ID: 9512218
    [No Abstract]   [Full Text] [Related]  

  • 6. Amelioration of hyperglycemia in streptozotocin-induced diabetic rats receiving a marginal mass of islet grafts by troglitazone, an oral antidiabetic agent.
    Nagai T; Yasunami Y; Nagata N; Ryu S; Ono J; Ikeda S
    Pancreas; 1996 Nov; 13(4):381-7. PubMed ID: 8899798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone (CS-045) ameliorates albuminuria in streptozotocin-induced diabetic rats.
    Fujii M; Takemura R; Yamaguchi M; Hasegawa G; Shigeta H; Nakano K; Kondo M
    Metabolism; 1997 Sep; 46(9):981-3. PubMed ID: 9284882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular effects of the thiazolidinedione troglitazone].
    Yamada K; Kuzuya H; Nakano T
    Nihon Rinsho; 2000 Feb; 58(2):435-9. PubMed ID: 10707572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning to use troglitazone.
    Riddle MC
    Diabetes Care; 1998 Sep; 21(9):1389-90. PubMed ID: 9727881
    [No Abstract]   [Full Text] [Related]  

  • 10. Troglitazone decreases collagen accumulation in prediabetic stage of a type II diabetic rat model.
    Yao L; Mizushige K; Noma T; Murakami K; Ohmori K; Matsuo H
    Heart; 2000 Aug; 84(2):209. PubMed ID: 10908265
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
    Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J
    N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone and small low-density lipoprotein in type 2 diabetes.
    Hirano T; Yoshino G; Kazumi T
    Ann Intern Med; 1998 Jul; 129(2):162-3. PubMed ID: 9669982
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin-sensitising agents in polycystic-ovary syndrome.
    Sattar N; Hopkinson ZE; Greer IA
    Lancet; 1998 Jan; 351(9099):305-7. PubMed ID: 9652605
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of troglitazone measured by insulin resistance index.
    Nagasaka S; Iwamoto Y; Ishikawa S; Kuzuya T; Saito T
    Lancet; 1997 Jul; 350(9072):184. PubMed ID: 9250189
    [No Abstract]   [Full Text] [Related]  

  • 15. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
    Fujibayashi K; Nagasaka S; Itabashi N; Kawakami A; Nakamura T; Kusaka I; Ishikawa S; Saito T
    Diabetes Care; 1999 Dec; 22(12):2088-9. PubMed ID: 10587851
    [No Abstract]   [Full Text] [Related]  

  • 16. Is troglitazone a real indication for obese subjects with impaired glucose tolerance?
    Yoshioka K; Yokoo S; Yoshida T; Kondo M
    Diabetes Care; 1997 Aug; 20(8):1340-1. PubMed ID: 9250469
    [No Abstract]   [Full Text] [Related]  

  • 17. A potential solution for the shortage of donors in islet transplantation using a novel oral antidiabetic agent, troglitazone.
    Nagai T; Yasunami Y; Nagata N; Ryu S; Ono J; Ikeda S
    Transplant Proc; 1995 Dec; 27(6):3405. PubMed ID: 8540020
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of troglitazone on insulin sensitivity.
    Henry RR
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
    Bloomgarden ZT
    Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of troglitazone on lipoprotein(a) levels in obese subjects.
    Tack CJ; Smits P; DeMacker PN; Stalenhoef AF
    Diabetes Care; 1999 Oct; 22(10):1752-3. PubMed ID: 10526754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.